Group 1 - The Hang Seng Index fell by 0.55%, down 131 points, closing at 23,695 points, while the Hang Seng Tech Index decreased by 0.66% [1] - The early trading volume in Hong Kong stocks reached HKD 1,076 million [1] - Robot-related stocks were active, with DCH Holdings (00179) rising nearly 6% and SUTENG (02498) increasing over 2% due to the upcoming CMG World Robot Competition [1] Group 2 - Eucan Vision Bio-B (01477) surged over 18% after OT-703 was approved for real-world research in Boao, Hainan [2] Group 3 - Smoore International (06969) rose over 5% as Glo Hilo is set to launch in Japan, with positive feedback from the trial market for heated non-combustible products [3] - Youjia Innovation (02431) increased over 5% after its L4 autonomous driving minibus received project designation, following a series of product showcases at the Shanghai Auto Show [3] Group 4 - Maanshan Iron & Steel (00323) saw a rise of over 7% as the steel industry showed improving performance in Q1, with institutions noting a marginal improvement in the sector's fundamentals [4] - InnoCare Pharma (02577) surged over 15% due to a partnership with NVIDIA for the next-generation 800V power architecture, drawing attention to third-generation semiconductors [4] Group 5 - Gu Ming (01364) increased by 4.5%, reaching a new high, with expectations of being included in the Hong Kong Stock Connect next month and a projected net increase of over 2,000 stores for the year [5] Group 6 - Dekang Agriculture and Animal Husbandry (02419) rose over 7%, with stock prices hitting a new high as institutions are optimistic about the company's valuation recovery potential [6] Group 7 - Gome Retail (06808) saw an early rise of nearly 7%, reporting a turnaround with a profit of RMB 410 million for the year, while Dehong Capital will promote the development of various store formats [7] - New Town Development (01030) fell over 3% amid reports of plans to issue guaranteed bonds domestically, aiming to raise RMB 1.5 to 2 billion [7] - Alibaba Health (00241) dropped over 4%, despite a year-on-year profit increase of over 62%, with analysts stating that profits did not meet expectations [7]

Group 1 - Glo Hilo series will launch in Japan on June 9, 2025, starting with a pilot in Sendai before nationwide rollout [1] - The Glo Hilo electronic cigarette features two models: a basic version with a 76g weight and a Plus version with a modular design weighing 107g, both offering different battery life and charging capabilities [1] - The phased rollout strategy aims to optimize product strategy through small-scale testing [1] Group 2 - Innovative electronic cigarette solutions include STAR RING, the world's first fingertip gyroscope e-cigarette, and SQUEEZY POD, the world's first tactile cartridge e-cigarette, both designed for enhanced user experience [2] - The company is entering a new product capacity release cycle, with positive feedback expected from the Japanese market launch in June, potentially expanding into the European and American markets [2] - Long-term projections indicate significant market share growth for the Glo series compared to IQOS, with expected revenue growth rates of 10.9%, 19.08%, and 16.63% for 2025-2027 [2]

智通财经APP获悉，截止5月16日收盘，有54只股票创52周新高，其中光荣控股(09998)、建德国际控股 (00865)、勋龙(01930)创高率位于前3位，分别为72.62%、25.86%、25.00%。 52周新高排行 | 股票名称 | 收盘价 | 最高价 | | 创高率 | | --- | --- | --- | --- | --- | | 光荣控股(09998) | 0.209 | 0.290 | 72.62% | | | 建德国际控股(00865) | 0.054 | 0.073 | 25.86% | | | 勋龙(01930) | 0.370 | 0.500 | 25.00% | | | 声通科技(02495) | 598.000 | 633.500 | 20.67% | | | CLSA PREMIUM(06877) | 0.510 | 0.560 | 19.15% | | | 北青传媒(01000) | 0.540 | 0.560 | 16.67% | | | 正大企业国际(03839) | 2.030 | 2.440 | 16.19% | | | 梁志天设计集团(02262) | 1.04 ...

| 思摩尔国际 HK 06969 ■ BMP基础行情 ■ 香港交易所 ■ 沪深港通标的股票 | | | 所属行业 ▼ 家庭电器及用品 | | | --- | --- | --- | --- | --- | | 17.320 港元 +1.600 +10.18% 已收盘 05-14 16:00:00 北京时间 | | | 概览 | 资: | | 今开 15.900 最高 | 17.320 | 成交量 | 8623万股 | 总市值 ▼ | | 15.720 昨夜 最低 | 15.700 | 成交额 | 14.49亿 | 总股本 | | 换手率 1.39% 振幅 | 10.31% | 量比 | 3.19 | 市盈(TTM) | | 分时 五日 目K 周K 月K | | 41 年K | | | | 均线 MA5 15.012 MA10 14.294 MA20 13.279 | | | | | | 17.320- | | | | | | 13.085 | | | | | | 8.850 | | | 8.850. | | 5月14日，港股的思摩尔国际（06969.HK）大涨10.18%，收报17.32港元/股，市值1071 ...

Market Overview - Hong Kong stocks surged today, with all three major indices rising over 2%. The Hang Seng Index increased by 2.3% or 532.38 points, closing at 23640.65 points, with a total turnover of 2228.41 million HKD [1] - The positive sentiment in the market is attributed to the unexpected progress in the first round of trade negotiations between China and the US, which is expected to continue in a constructive direction [1] Blue-Chip Stocks Performance - JD Health (06618) saw a notable increase of 5.13%, closing at 39.95 HKD, contributing 3.56 points to the Hang Seng Index. The company reported Q1 2025 revenue of 16.645 billion RMB, a year-on-year growth of 25.5%, and operating profit of 1.071 billion RMB, up 119.8% [2] - Other blue-chip stocks included China Life (02628) rising by 6.55% to 16.26 HKD, AIA (01299) up 5.15% to 65.3 HKD, while Link REIT (00823) fell by 1.34% to 40.45 HKD [2] Sector Performance - Large technology stocks collectively rose, with Baidu increasing over 4% and Alibaba and JD both rising over 3% [3] - Financial stocks experienced a significant rally, with China Pacific Insurance (02601) up 6.77% to 24.45 HKD, China Life (02628) up 6.55%, and GF Securities (01776) up 6.31% to 11.46 HKD [3] Shipping Sector - The shipping sector performed well, with Pacific Basin Shipping (02343) rising by 7.78% to 1.94 HKD and Seafront International (01308) up 6.51% to 22.9 HKD. The improvement is linked to the easing of tariff conflicts and a seasonal increase in container shipping demand [4][5] Automotive Sector - The automotive sector saw widespread gains, with Li Auto (02015) rising by 4.54% to 112.8 HKD and Xpeng Motors (09868) up 3.87% to 81.8 HKD. The retail sales of new energy passenger vehicles reached 905,000 units in April, a year-on-year increase of 33.9% [6][5] Coal Sector - The coal sector showed positive movement, with China Coal Energy (01898) up 4.91% to 8.55 HKD. Despite recent price declines, analysts suggest that demand may improve as summer approaches [7] Notable Stock Movements - Tencent Music (01698) surged by 12.84% to 61.5 HKD, reporting Q1 2025 revenue of 7.36 billion RMB, with online music service revenue growing by 15.9% [8] - Smoore International (06969) reached a new high, increasing by 10.18% to 17.32 HKD, amid rising sales of new tobacco products [9] - MicroPort Scientific (02252) saw a decline of 8.12% to 16.52 HKD due to a share placement announcement [10] - Samsonite (01910) dropped by 8.58% to 14.06 HKD after reporting a 7.3% decrease in net sales for Q1 2025 [11]

思摩尔国际(06969.HK)午后冲高，现涨9.7%。 ...

智通财经5月13日电，思摩尔国际午后短线冲高，现涨近12%，报15.9港元。 ...

该行认为，国际烟草巨头贯彻无烟化战略，菲莫Q1取得强劲开局，HNB增长符合预期、美国市场有序 推进，看好新型烟草供应链核心标的思摩尔国际。其中HNB 市场潜力仍然较大，且HNB较雾化烟在监 管上更占优(对青少年低吸引力、减害性更易论证)，竞争格局更好(参与厂商少)，同时英美烟草的新一 代Glo Hilo产品无论横向对比市面上的领军产品IQOS iluma i或是纵向对比上一代老产品均有显著的性能 和使用体验提升，看好其在25-26年逐渐拓展至更多市场、迎来放量，思摩尔做为GLO HILO核心供应 商，有望受益。 智通财经APP获悉，思摩尔国际(06969)涨超3%，截至发稿，涨2.36%，报13港元，成交额7316.81万港 元。 浙商证券发布研报称，4月23日，菲莫国际发布2025Q1业绩，IQOS作为HNB市场份额70%+的领军产 品，从其经营表现感知行业成长，对思摩尔的HNB业务潜力具备指导意义。25Q1菲莫国际SFP(Smoke- Free Products)收入同比+20.4%，毛利同比+33.1%，毛利率超过70%、同比提高6.7pct，且比传统烟高出 5pct；出货量同比+14.4%，其中HNB ...

证券研究报告 | 公司点评 | 家居用品 思摩尔国际(06969) 报告日期：2025 年 04 月 24 日 菲莫一季报再次印证新型烟草大势，持续布局 ——思摩尔国际点评报告 投资要点 ❑ 事件：4.23 菲莫国际发布 2025Q1 业绩，IQOS 作为 HNB 市场份额 70%+的领军 产品，从其经营表现感知行业成长，对思摩尔的 HNB 业务潜力具备指导意义。 3）美国 HNB 市场即将打开：美国市场 3 月底在德州试销收到了强烈的市场反 馈，未来几个月进行更多的试点。 4）对 25 年 IQOS 的指引：维持此前 25 全年烟支销量同比增长 10-12%（24 年达 到 1400 亿支、同比+11.6%）的指引，管理层预计今年剩余时间 IQOS 将保持双 位数增长。 5）菲莫 HNB 烟弹 25Q1 在全球市场的份额为 5.7%（同比+0.6pct），在日本市 场达到 32.2%（24Q4 为 30.6%） ❑ 新型口含烟 ZYN 表现亮眼，雾化电子烟开始起量，稳步迈向"无烟气未来" 1）新型口含烟：尼古丁袋 ZYN 在美国 25Q1 出货量 2.02 亿罐（同比+53%）， 在美国以外的国际市场同样取 ...

Financial Performance - Total revenue for 2024 was RMB 11,798.662 million, representing a 5.3% increase from RMB 11,203.250 million in 2023[10] - Gross profit for 2024 was RMB 4,411.969 million, with a gross margin of 37.4%, down from 38.7% in 2023[10] - Net profit for 2024 decreased to RMB 1,303.255 million, reflecting a net profit margin of 11.0%, compared to 14.7% in 2023[10] - The company achieved revenue of approximately RMB 11,798.66 million in the review period, representing a year-on-year growth of about 5.3%[27] - The group's total revenue for the year ended December 31, 2024, was approximately RMB 11,798,662 thousand, representing a 5.3% increase from RMB 11,203,250 thousand in 2023[72] - The gross profit for the review period was approximately RMB 4,411,969 thousand, a 1.6% increase from RMB 4,340,911 thousand in 2023, with a gross margin decrease from 38.7% to 37.4%[73] Asset Management - The company reported a significant increase in non-current assets, reaching RMB 10,807.950 million in 2024, up from RMB 5,937.532 million in 2023[10] - Current assets decreased to RMB 16,846.428 million in 2024 from RMB 19,570.752 million in 2023, while current liabilities increased to RMB 5,259.365 million[10] - The asset-liability ratio increased to 20.8% in 2024 from 16.1% in 2023, indicating a higher proportion of liabilities relative to total assets[12] - As of December 31, 2024, the group's current assets net value was approximately RMB 11,587,063 thousand, down from RMB 16,004,419 thousand in 2023[86] - The group's current ratio as of December 31, 2024, was approximately 320.3%, a decrease from 548.8% in 2023[87] - The asset-liability ratio as of December 31, 2024, was approximately 26.2%, compared to 19.1% in 2023[90] Dividend and Shareholder Information - The company plans to declare a final dividend of HKD 0.05 per ordinary share for the year ended December 31, 2024[11] - The board has proposed a final dividend of HKD 0.05 per ordinary share for the year ending December 31, 2024, subject to approval at the upcoming annual general meeting[166] - The company's distributable reserves as of December 31, 2024, amount to RMB 7,047.7 million[161] Business Segments and Growth - The electronic vaporization segment showed positive growth due to increased regulatory enforcement against non-compliant products, leading to a shift in consumer demand towards compliant products[14] - The company successfully launched new business lines in heated non-combustible products and aerosol medical and beauty products, contributing to overall business diversification[14] - In the heating non-combustion product sector, the company plans to support strategic clients in launching products in more markets, focusing on user feedback for continuous product iteration[20] - The company successfully launched the "Lan Zhi" brand in the aerosol beauty business, which has gained recognition through online promotions and offline channels, achieving impressive sales during major marketing events[16] - The company anticipates that 2025 will be a critical year for the second growth curve, with plans to expand into harm reduction products and strengthen its competitive edge in core businesses[21] - The group launched multiple new product series in overseas markets across various segments, including electronic vaporization and medical vaporization, enhancing R&D efficiency through scientific classification management[29] Research and Development - The company is committed to increasing R&D investment, particularly in aerosol medical and heating non-combustible products, which have shown satisfactory breakthroughs during the review period[16] - Research and development expenditure for the period was approximately RMB 1,572,313 thousand, an increase of 6.0% year-on-year, accounting for about 13.3% of total revenue[48] - R&D expenditure for electronic nicotine delivery systems was RMB 1,034,668 thousand, accounting for 65.8% of total R&D spending, with a slight increase of 0.1% year-on-year[52] - R&D expenditure for medical and beauty aerosol products increased by 41.3% year-on-year to RMB 392,180 thousand, accounting for 24.9% of total R&D spending[52] - The company filed a total of 1,558 new patent applications globally during the period, including 893 invention patents, bringing the cumulative total to 9,253 patents[51] Market and Regulatory Environment - The group achieved a revenue contribution of approximately 37.4% from the U.S. market during the review period, with significant legal and regulatory developments impacting the electronic nicotine delivery systems (ENDS) products[33] - The FDA has taken action on over 99% of PMTA submissions, with ongoing legal challenges affecting several ENDS products[33] - The UK has not introduced any significant laws or regulations related to electronic cigarettes and vaping devices as of December 31, 2024, contributing 25.5% to revenue[34] - In the EU, countries with flavor restrictions include Finland, Estonia, Hungary, and others, with a revenue contribution of 7.9%[34] - Hong Kong has proposed a complete ban on alternative smoking products, which is expected to impact 32.8% of revenue by December 31, 2024[36] - The mainland China market's revenue contribution is approximately 2.2%, with new regulations being implemented in July-August 2024[36] Corporate Governance - The board consists of eight directors, including three independent non-executive directors, ensuring sufficient checks and balances within the board[109] - The company has adopted the corporate governance code and complied with all provisions except for the separation of the roles of chairman and CEO, which are held by the same individual[108] - The independent non-executive directors reviewed and confirmed that the related party transactions were conducted on fair and reasonable terms[105] - The company has established a clear process for the appointment and re-election of directors, with terms set at three years[115] - The company has implemented an anti-corruption policy to prevent bribery and corruption within its operations[130] Employee and Gender Diversity - Overall employee gender ratio is 48.14% female (8,939) and 51.86% male (9,631) across the company[124] - The company has appointed one female executive director and one female non-executive director as of December 31, 2024[122] - The board consists of 25% female members (2 out of 8) and 75% male members (6 out of 8) as of December 31, 2024[124] - The company emphasizes gender diversity in recruitment and selection processes at all levels[122] Risk Management - The company’s risk management and internal control systems aim to manage operational efficiency and ensure compliance with relevant laws and regulations[142] - The Board has confirmed the effectiveness of the risk management and internal control systems as of December 31, 2024[144] - The company's overall risk management process is integrated into daily operations, with management responsible for identifying and responding to risks[144] Stock Options and Incentives - The company has granted a total of 129,524,700 stock options, with 98,158,700 options currently exercisable[193] - The share incentive plan aims to recognize and reward contributions from eligible participants to the group's growth and development, while also attracting suitable personnel[195] - The maximum number of shares that can be held under the plan at any time is capped at 2% of the total issued shares (excluding treasury shares)[198] - The total number of shares issued to each eligible participant under the plan within any 12-month period cannot exceed 1% of the total issued shares (excluding treasury shares)[200]